CHAD SCHOENMANN: Open Payments
NPI 1740578863 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,351 in 148 payments from 20 companies in 2025. Trend: 2023 $1,909 · 2024 $3,628 · 2025 $2,351
Food & beverage: $2,244Education: $107
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $349 |
| LEO Pharma Inc. | 16 | $242 |
| GENZYME CORPORATION | 7 | $211 |
| Janssen Biotech, Inc. | 9 | $199 |
| E.R. Squibb & Sons, L.L.C. | 10 | $189 |
| Regeneron Healthcare Solutions, Inc. | 10 | $184 |
| ABBVIE INC. | 19 | $164 |
| Lilly USA, LLC | 10 | $148 |
| Galderma Laboratories, L.P. | 11 | $144 |
| UCB, Inc. | 6 | $126 |
Products named: DUPIXENT, COSENTYX, TREMFYA, Sotyktu, ADBRY, NEMLUVIO, Bimzelx, EBGLYSS.
Industry payments across GA — which companies pay providers there.
